Startup Valuation 2026: 5 Methods to Defend Your Price

You are preparing a fundraising round in 2026. One question dominates the table: how much is your startup actually worth? The number you announce to a fund determines the dilution you will accept, the share of capital you give up, the depth of the future BSPCE pool and, indirectly, your strategic freedom for the next 18 months.

The challenge is not technical, it is political: an investor wants to minimise the pre-money valuation, you want to maximise it without breaking trust. Between the two lies a zone of objectivity — a set of methods that funds genuinely use to frame their offer, and that you must master to defend your price.

This article reviews the five dominant startup valuation methods in 2026, their limits, their use cases and how a founder combines them to produce a credible price. We deliberately separate fundraising / venture capital valuation from M&A valuation, which is covered in our companion piece on company valuation methods and mistakes to avoid.

• At early stage, valuation is negotiated, not calculated. Methods frame the debate; they do not produce a single right price.
• Five methods dominate: Berkus (pre-revenue), scorecard (qualitative comparables), VC method (driven by target exit), startup-friendly DCF (post-revenue, credible plan), ARR multiple (SaaS, post-product-market-fit).
• In 2026, with tighter rates and renewed LP discipline, funds apply stricter haircuts to projections: SaaS ARR multiples are down 30 to 40 % versus the 2021 peak.
• The right founder reflex is to defend not a price, but a range backed by two or three converging methods.
• The most expensive mistake is not a low seed valuation: it is an inflated pre-money that weakens the next Series A (down round risk and full ratchet).

A mature SME generates a stable result, a readable EBITDA, identifiable assets. You value it from historical data: sector EBITDA multiples, revalued net assets, historical cash flows.

A startup raising funds, on the contrary, is worth essentially what it has not yet produced: proven revenue, market share, cash generation. Valuation therefore prices a potential — making the exercise fundamentally asymmetric between founder and investor.

Three concrete consequences:

• Asset-based methods are inoperative for pre-revenue. The book net assets of a seed-stage startup boil down to partially burnt cash.
• Historical cash flows cannot be used: they are negative by construction.
• Valuation is a negotiation act more than a measurement act. Methods frame the discussion, but the final price depends on power balance, market timing and dossier quality.

The political nature of the figure explains why a founder must enter discussions with multiple angles rather than a single number. For a broader view of financing trade-offs, see Funding your SME in 2026: balancing debt, equity and public support.

2.1. Berkus method (pre-revenue, pre-seed and early seed)#

Designed by investor Dave Berkus, this method assigns up to EUR 500,000 (or USD) to each of five qualitative startup factors:

• quality of the idea and depth of the problem addressed;
• prototype or MVP maturity;
• founding team quality;
• strategic partnerships already signed;
• initial commercial deployment.

Theoretical cap: EUR 2 to 2.5 m pre-money. The method is useful for French pre-seed rounds between EUR 500 k and EUR 2 m of valuation, where no accounting figure is exploitable. Its virtue: it objectivises what many funds estimate by gut feeling, and lets a founder defend a price item by item.

Main limit: the cap mechanically caps the discussion at EUR 2.5 m. For a deeptech with patents or a team coming from a prior exit, it systematically underprices.

2.2. Scorecard method (Bill Payne, qualitative comparables)#

You identify the median valuation of comparable deals in your geography and stage (e.g. seed B2B SaaS France 2025: median around EUR 4 to 6 m pre-money based on available public databases), then you apply a coefficient on six weighted criteria:

• team (30 %);
• market size (25 %);
• product / technology (15 %);
• competitive environment (10 %);
• sales channel / partnerships (10 %);
• future financing needs (10 %).

If your startup scores 1.2 on the sector median, your theoretical valuation is 1.2 × EUR 5 m = EUR 6 m pre-money. The method is well-liked by early-stage funds because it aligns with their portfolio.

Its quality depends on comparables data reliability. In 2026, public sources (Crunchbase, Dealroom, France Digitale Tech Tour) remain imperfect for the French market: a founder must cross several sources and accept a range rather than a point.

2.3. VC method (driven by target exit)#

This is the funds' preferred method. The reasoning is reversed: you start from the target exit (10-year sale, IPO) and work back to current valuation.

Mechanics:

1. Estimate revenue at exit (e.g. EUR 50 m ARR in 7 years).
2. Apply a sector exit multiple (e.g. 6× ARR for B2B SaaS → exit EUR 300 m).
3. Define the fund's expected return on the position (typically 10× to 20× on a seed, 3× to 5× on a Series C).
4. Compute the current post-money valuation that delivers this return given expected dilution on future rounds.

Example: exit at EUR 300 m, fund targets 15× on its initial cheque, future cumulative dilution estimated at 50 % → the fund's position must be worth EUR 40 m at exit, i.e. after dilution a current 13.3 % stake bought today. If the fund invests EUR 1 m, post-money valuation = EUR 7.5 m, pre-money = EUR 6.5 m.

Why this matters to a founder: understanding the mechanics lets you identify the fund's optimistic or pessimistic assumptions and argue on the exit multiple or future dilution, rather than on the price itself.

2.4. Startup-friendly DCF (post-product-market-fit)#

Classic DCF is unusable at seed (negative flows, volatile assumptions). However, once Series A is confirmed (recurring revenue, stabilised growth rate, readable gross margin), a variant works: DCF over 5 to 7 years with terminal value, high discount rate (20 to 30 %) reflecting startup risk.

Watch points:

• the terminal value often represents 70 to 85 % of total valuation — it is the figure to defend;
• the discount rate is more strongly negotiated than the flows;
• the method remains subjective but disciplines the business plan and exposes inconsistencies (projected growth incompatible with gross margin, for instance).

At this stage, an in-house or fractional CFO can build a DCF model coherent with the shareholders' agreement and capital structure. See our fractional CFO for startups and SMEs.

2.5. ARR multiple (SaaS post-product-market-fit)#

The dominant method for SaaS at Series A, B and beyond. Simple: valuation = ARR × sector multiple, adjusted by growth.

2026 reference points (indicative ranges, always cross-check):

The multiple depends as much on quality as on growth: net revenue retention (NRR), churn, magic number, SaaS gross margin, gross dollar retention. A SaaS at 80 % growth but 30 % gross churn will be valued lower than a SaaS at 50 % growth and 5 % churn.

Compared to the 2021 peak, 2026 multiples are down 30 to 40 % on comparable segments. A founder who anchors on 2020-2021 deals will systematically overestimate.

Recommendation: a seed founder combines Berkus + scorecard + VC method; a Series A founder combines VC method + DCF + ARR multiple. Three converging methods beat one precise method.

Beyond methods, six levers determine final valuation:

• Demonstrable traction quality — qualified pipeline, letters of intent, audited MRR/ARR.
• Defensible technology — filed patents, up-to-date INPI registrations, documented proprietary know-how.
• Team track record — prior exits, sector operating experience.
• Process competition — multiple parallel term sheets mechanically lift the pre-money.
• Business plan robustness — a coherent BP, scenario-modelled (base / high / low), with an auditable financial model, is worth 0.5 to 1 multiple point.
• Ability to fund R&D differently — French research tax credit (CIR), Young Innovative Company status (JEI), Bpifrance grants reduce the equity need, hence accepted dilution. See Innovation funding: CIR, CII, JEI and our CIR JEI startup simulator.

Conversely, these elements destroy valuation: excessive founder dependency, customer concentration > 30 %, gross churn > 25 %, insufficient option pool post-deal (an investor will require expansion before closing, retroactively diluting pre-money), accounting opacity.

Three angles VC literature underplays:

Angle 1 — Accounting/tax coherence of the BP. A business plan projecting 30 % net margin from year three without accounting for the move to mature SME standards (CSRD, statutory audit beyond thresholds, social charges on BSPCE not yet exercised) is immediately disqualified by an experienced fund. Real valuation is what the investor is willing to pay after restating your BP with their own prudential assumptions.

Angle 2 — Valuation impact on BSPCE. The strike price of BSPCE granted to key talent is anchored to the last capital increase (article 163 bis G of the French Tax Code, BOFiP doctrine). An inflated seed valuation increases the strike of subsequently issued BSPCE and reduces the incentive effect on the team. See our piece on BSPCE: pros, cons, 2026 user manual.

Angle 3 — Coherence with the shareholders' agreement. A defensible pre-money valuation is not enough if it comes with aggressive economic clauses on the investor side (liquidation preference > 1×, full ratchet, preferred dividends). The headline price can be a lure. The founder's true economic value depends on the combined term sheet + shareholders' agreement. See French shareholders' agreement 2026: 15 essential clauses.

The BP is not a marketing document. It is the main support of financial due diligence and the verification base for valuation assumptions. In 2026, funds use automated analysis tools that detect classic inconsistencies in minutes:

• ARR growth uncorrelated with the sales hiring plan;
• SaaS gross margin inconsistent with projected cloud infrastructure;
• CAC payback period below sector benchmarks without justification;
• understated personnel costs (omitting profit-sharing, social charges on exercised BSPCE, bonus components);
• absence of alternative scenarios (base / high / low).

A founder presenting a scenario-based, line-by-line auditable BP gains 1 to 2 multiple points on final valuation. Conversely, a linear, optimistic, opaque BP triggers a prudential discount of 20 to 30 %.

Four structural decisions, before entering negotiation:

• Target range — low, mid, high. The low is your BATNA (best alternative to a negotiated agreement). Below it, you walk away.
• Maximum acceptable dilution — typically 15 to 25 % at seed, 18 to 25 % at Series A. Above it, you delay the round.
• Post-money BSPCE pool size — often pushed to 10-15 % by the investor. The bigger the pool, the higher the founder's effective dilution.
• Non-negotiable economic clauses — no participating liquidation preference, no full ratchet, founder vesting capped at 4 years with a 1-year cliff.

These four parameters are more decisive than the headline valuation. A founder can accept a 20 % lower valuation in exchange for clean clauses; the reverse is rarely true.

• LP discipline — early-stage funds have sharply tightened criteria. A BP that flew in 2021 is rejected today.
• SaaS ARR multiples — structural retreat of 30 to 40 % vs the 2021 peak. Build an argument that owns this new norm.
• CIR/JEI — 2026 trajectory is stable, but tax audits on eligibility have intensified. A fragile CIR file mechanically weakens valuation.
• 2026 e-invoicing — a compliance gap detected in due diligence is a negative signal.
• Geographic concentration of funds — Paris remains dominant, but regional funds (Lyon, Bordeaux, Lille) apply ranges 15 to 25 % below Paris medians.

• Build a scenario-based financial model (base / high / low) over 5 years.
• Document every revenue assumption (pipeline, conversion rate, ARPU).
• Compute three valuations using three different methods; produce the consolidated range.
• Identify 5 to 10 comparable deals (geography, stage, sector) over the past 12 months.
• Audit 2024-2025 accounts with your firm: payroll declarations, VAT, social charges, CIR.
• Verify 2026 e-invoicing compliance.
• Prepare a structured data room: legal, financial, HR, technical, commercial.
• Secure the existing shareholders' agreement to accommodate the upcoming round (anti-dilution, preferential subscription rights).
• Define the target range and BATNA internally, before any pitch.
• Run multiple parallel VC conversations to create real competition.

Which valuation method do French funds use most in 2026?

At seed: scorecard + VC method, cross-checked with Berkus for pre-revenue. At Series A and beyond: VC method + ARR multiple for SaaS, DCF for businesses with readable gross margin. No method is used alone: funds reason in converging ranges.

How do you justify a pre-money valuation above EUR 10 m at seed?

Three cumulative conditions: team with prior exit or recognised sector track record, demonstrated traction (MRR/ARR > EUR 50 k for SaaS), defensible technology (patents, know-how). Without one of these three pillars, a fund will systematically apply a discount.

Should you accept a "pre-money" option pool?

Almost always imposed by investors, the "pre-money" option pool retroactively dilutes founders. The negotiation is on the size (typically 10-12 %, sometimes 15 %) rather than the principle. Asking for a "post-money" pool is possible but rarely won at Series A.

How do you avoid a down round at Series A?

By under-promising at seed. A EUR 5 m pre-money seed with 4× ARR growth over 18 months supports a comfortable Series A at EUR 20-25 m. A EUR 10 m pre-money seed on the same profile makes Series A flat or down — triggering anti-dilution and ratchet clauses.

Is an auditor of contributions (commissaire aux apports) required to validate the valuation?

A commissaire aux apports is required for in-kind contributions (article L.225-8 of the French Commercial Code). For a cash capital increase with an external investor, their intervention is not mandatory, but the shareholders' agreement may require a prior audit. Valuation remains freely negotiated between the parties subject to prudential evaluation rules.

Valuation is not a number, it is a defensible range. The founder who arrives in negotiation with three converging methods, an auditable scenario-based BP and a clean legal file mechanically gains 1 to 2 extra multiple points — and more importantly, preserves the strength of the next round.

Our firm advises startups raising funds on valuation preparation, business plan auditing, due diligence dossier structuring and shareholders' agreement protection. For a free review of your fundraising file, contact us via the fractional CFO for startups and SMEs page or book a meeting directly with a partner.

• French Commercial Code, article L.225-8 (auditor of contributions) — Légifrance.
• French Commercial Code, articles L.227-1 et seq. (SAS, capital increases) — Légifrance.
• French Tax Code, article 163 bis G (BSPCE tax regime) — BOFiP.
• Company valuation reference — Banque de France.
• Professional valuation guide — Ordre des Experts-Comptables (French Institute of Chartered Accountants).
• AMF — doctrine on financial information and issuer valuation.

Up to date as of 1 May 2026.